PNC-28 10mg

PNC-28 is a synthetic p53-derived research compound studied in laboratory settings for its molecular interactions with HDM-2, membrane-associated targets, and related cellular pathways.

Structural Composition

PNC-28 consists of:

• A p53-derived sequence containing a region associated with HDM-2 interactions.
• A membrane-interacting sequence studied for its relationship with cellular membrane activity.

This structure provides a laboratory model for investigating molecular interactions between p53-derived sequences and membrane-associated targets.

Mechanism & Molecular Research

1. Target Interaction

• Laboratory research examines PNC-28 interactions with membrane-associated HDM-2.
• Research investigates the molecular characteristics associated with these interactions.

2. Membrane Interaction

• In vitro studies examine PNC-28 in relation to membrane structure and permeability.
• Its molecular characteristics provide a model for investigating compound-membrane interactions.

3. Cellular Response

• Laboratory research investigates cellular responses associated with PNC-28 membrane interactions.
• These studies examine associated molecular and cellular signaling mechanisms.

Key Research Areas

• HDM-2 Interaction Research — Investigation of PNC-28 interactions with membrane-associated HDM-2.
• Membrane Research — Laboratory examination of membrane interactions, permeability, and associated molecular characteristics.
• p53-Associated Pathway Research — Investigation of molecular pathways associated with the p53-derived structure of PNC-28.
• Cellular Signaling Research — Examination of cellular and molecular signaling associated with PNC-28.
• Comparative Molecular Research — Comparative investigation across controlled in vitro laboratory systems.

For laboratory and research use only. Not intended for human or animal consumption, diagnostic, or therapeutic use. Not a drug, dietary supplement, or cosmetic.